Data and digital is a force to reckon with when it comes to India
Suneela Thatte highlighted that while the GCC was initially set up for cost savings in drug development, the focus has shifted to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
R&D
Budget 2024-25 prioritises R&D, education and business for MSMEs
Industry stakeholders appreciate the efforts made towards increasing employment, skill-building and implementation of various…
OPPI urges government to boost R&D and innovation in pharma sector ahead of Union Budget
Anil Matai, Director General of OPPI, highlights key recommendations for enhancing pharmaceutical development in India
ENTOD Pharma launches new R&D centre in Navi Mumbai
The facility will focus on developing next-generation molecules using generative AI platforms, particularly in the ophthalmic,…
Budget expectation: Focus on encouraging R&D in pharma sector
Sanjay Vyas, Executive Vice President and Managing Director, Parexel India shares his budget expectations
As we look ahead to 2024, pharma sector is poised for sustained growth and innovation
Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) shares that in 2024, we anticipate a…
Ceremorphic demonstrates BioCompDiscoverX supercomputing platform for accelerated drug discovery
The BioCompDiscoverX will be available in Q3 2024 and will include technologies incorporated in its proprietary silicon device
Glenmark Pharma hosts drug discovery workshop for Sion Hospital students
The tour was aimed at encouraging medical students to explore new horizons in their academic journey
IIT Kanpur, University at Buffalo sign agreement for R&D in Biomedicine & Bioengineering
The agreement would provide the scope for joint research, exchange of students and researchers, and exchange of academic…
Tough market conditions fail to deter discussions about R&D investments, new technologies:…
Companies are actively investing in research and development (R&D), projects, and technologies